Close Menu

Cornell

This Week in PNAS

In PNAS this week: differential gene expression predictor, clonal evolution dynamics in colorectal cancer, and more.

Early-access users have used IDT's rhAmpSeq technology to create genetic marker maps for plants and to validate off target events in gene editing.

 

This Week in Science

In Science this week: reduction in bee phylogenetic diversity, and more.

This Week in Nature

In Nature this week: genomic analysis of Aspergillus, atlas of genetic associations in the UK Biobank, and more.

In Nucleic Acids Research this week: Pseudomonas aeruginosa reference database, online catalog of genomic regions under selection in humans, and more.

Using a microfluidics-based single-cell isoform RNA-seq approach, researchers clustered cerebellar cells and saw isoforms with cell type-specific expression.

This Week in Nature

In Nature this week: gene editing for tomato domestication, genome assemblies of inbred mouse strains, and more.

The university is arguing that the judge had no basis to compel arbitration of what Cornell is claiming is a fraudulent settlement.

Cornell claims that it was fraudulently induced into settling a patent-infringement lawsuit it filed with Life Tech against Illumina.

The consortium aims to identify tuberculosis protein targets and corresponding small molecule inhibitors that can be used to develop drugs to shorten therapy duration.

Pages

Two researchers are calling for education for scientists on defending facts.

Researchers were among those who marched in London this weekend to call for another vote on Brexit.

Duke has agreed to pay $112.5 million to settle a lawsuit regarding its handling of data falsified by biologist Erin Potts-Kant. 

In PLOS this week: genetic factors influencing inorganic arsenic metabolism and toxicity, a germline variant in the cell adhesion molecule-coding gene DSCAM, and more.